Respiratory Syncytial Virus Vaccines: Are We Making Progress?
作者信息
Mejias Asuncion, Rodriguez-Fernandez Rosa, Peeples Mark E, Ramilo Octavio
机构信息
From the Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH.
Division of Pediatric Infectious Diseases, Nationwide Children's Hospital, Columbus, OH.
出版信息
Pediatr Infect Dis J. 2019 Oct;38(10):e266-e269. doi: 10.1097/INF.0000000000002404.
Abstract
摘要
相似文献
1
Respiratory Syncytial Virus Vaccines: Are We Making Progress?呼吸道合胞病毒疫苗：我们有进展吗？
Pediatr Infect Dis J. 2019 Oct;38(10):e266-e269. doi: 10.1097/INF.0000000000002404.
2
Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis.了解呼吸道合胞病毒（RSV）疫苗的研发情况及疾病发病机制的相关方面。
Expert Rev Vaccines. 2016;15(2):173-87. doi: 10.1586/14760584.2016.1115353. Epub 2015 Dec 5.
3
Translational sciences approach to RSV vaccine development.呼吸道合胞病毒疫苗研发的转化科学方法。
Expert Rev Vaccines. 2013 Sep;12(9):1047-60. doi: 10.1586/14760584.2013.824706.
4
Recent advances in the development of subunit-based RSV vaccines.基于亚单位的 RSV 疫苗研发的最新进展。
Expert Rev Vaccines. 2016;15(1):53-68. doi: 10.1586/14760584.2016.1105134. Epub 2015 Oct 27.
5
In search of a vaccine for respiratory syncytial virus: the saga continues.寻找呼吸道合胞病毒疫苗：故事仍在继续。
J Infect Dis. 2005 Apr 1;191(7):1036-9. doi: 10.1086/427998. Epub 2005 Mar 1.
6
Development of respiratory syncytial virus (RSV) vaccines for infants.用于婴儿的呼吸道合胞病毒（RSV）疫苗的研发。
J Infect. 2017 Jun;74 Suppl 1(Suppl 1):S143-S146. doi: 10.1016/S0163-4453(17)30205-0.
7
Small hydrophobic protein of respiratory syncytial virus as a novel vaccine antigen.呼吸道合胞病毒的小疏水蛋白作为一种新型疫苗抗原
Immunotherapy. 2015;7(3):203-6. doi: 10.2217/imt.15.11.
8
Respiratory syncytial virus: reverse genetics and vaccine strategies.呼吸道合胞病毒：反向遗传学与疫苗策略
Virology. 2002 May 10;296(2):204-11. doi: 10.1006/viro.2002.1437.
9
Vaccine development for respiratory syncytial virus.呼吸道合胞病毒疫苗的研发
Curr Opin Virol. 2017 Apr;23:107-112. doi: 10.1016/j.coviro.2017.03.012. Epub 2017 May 16.
10
Identifying targets in the hunt for effective respiratory syncytial virus interventions.寻找有效的呼吸道合胞病毒干预措施的目标。
Expert Rev Respir Med. 2012 Apr;6(2):215-22. doi: 10.1586/ers.12.8.
引用本文的文献
1
Highly Effective mRNA-LNP Vaccine Against Respiratory Syncytial Virus (RSV) in Multiple Models.在多种模型中针对呼吸道合胞病毒（RSV）的高效mRNA-LNP疫苗
Vaccines (Basel). 2025 Jun 10;13(6):625. doi: 10.3390/vaccines13060625.
2
Respiratory Syncytial Virus Humoral Antibody Responses in Older Adults After Vaccination or Infection.老年人接种疫苗或感染后呼吸道合胞病毒的体液抗体反应
J Infect Dis. 2025 Jul 11;231(6):e1146-e1150. doi: 10.1093/infdis/jiaf149.
3
Integrating immunoinformatics and computational epitope prediction for a vaccine candidate against respiratory syncytial virus.整合免疫信息学与计算表位预测以研发针对呼吸道合胞病毒的候选疫苗
Infect Dis Model. 2024 Apr 16;9(3):763-774. doi: 10.1016/j.idm.2024.04.005. eCollection 2024 Sep.
4
Viral RNA N6-methyladenosine modification modulates both innate and adaptive immune responses of human respiratory syncytial virus.病毒 RNA N6-甲基腺苷修饰调节人类呼吸道合胞病毒的固有和适应性免疫反应。
PLoS Pathog. 2021 Dec 20;17(12):e1010142. doi: 10.1371/journal.ppat.1010142. eCollection 2021 Dec.
5
Role of age and birth month in infants hospitalized with RSV-confirmed disease in the Valencia Region, Spain.年龄和出生月份在西班牙巴伦西亚地区因 RSV 确诊疾病住院的婴儿中的作用。
Influenza Other Respir Viruses. 2022 Mar;16(2):328-339. doi: 10.1111/irv.12937. Epub 2021 Nov 24.
6
Human respiratory syncytial virus diversity and epidemiology among patients hospitalized with severe respiratory illness in South Africa, 2012-2015.南非 2012-2015 年住院严重呼吸道疾病患者中人类呼吸道合胞病毒的多样性和流行病学。
Influenza Other Respir Viruses. 2022 Mar;16(2):222-235. doi: 10.1111/irv.12905. Epub 2021 Sep 16.
7
Role of G2-S16 Polyanionic Carbosilane Dendrimer in the Prevention of Respiratory Syncytial Virus Infection In Vitro and In Vivo in Mice.G2-S16聚阴离子碳硅烷树枝状大分子在小鼠体内外预防呼吸道合胞病毒感染中的作用
Polymers (Basel). 2021 Jun 29;13(13):2141. doi: 10.3390/polym13132141.
8
Capturing respiratory syncytial virus season in Belgium using the influenza severe acute respiratory infection surveillance network, season 2018/19.利用 2018/19 年度流感严重急性呼吸道感染监测网络捕捉比利时呼吸道合胞病毒流行季节。
Euro Surveill. 2020 Oct;25(39). doi: 10.2807/1560-7917.ES.2020.25.39.1900627.
9
Stable Attenuation of Human Respiratory Syncytial Virus for Live Vaccines by Deletion and Insertion of Amino Acids in the Hinge Region between the mRNA Capping and Methyltransferase Domains of the Large Polymerase Protein.通过删除和插入大聚合酶蛋白的 mRNA 加帽和甲基转移酶结构域之间的铰链区中的氨基酸，稳定衰减人呼吸道合胞病毒用于活疫苗。
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.01831-20.
10
The journey to a respiratory syncytial virus vaccine.呼吸道合胞病毒疫苗研发之旅。
Ann Allergy Asthma Immunol. 2020 Jul;125(1):36-46. doi: 10.1016/j.anai.2020.03.017. Epub 2020 Mar 23.
本文引用的文献
1
Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory Illness.母乳预处理液 F 免疫球蛋白 G 作为预防呼吸道合胞病毒急性呼吸道疾病的保护相关因素。
J Infect Dis. 2019 Jan 1;219(1):59-67. doi: 10.1093/infdis/jiy477.
2
The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates.呼吸道合胞病毒疫苗领域：从墓地中吸取的教训和有前途的候选者。
Lancet Infect Dis. 2018 Oct;18(10):e295-e311. doi: 10.1016/S1473-3099(18)30292-5. Epub 2018 Jun 18.
3
Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics.呼吸道合胞病毒疫苗的研发：世界卫生组织技术路线图和优先产品特征。
Vaccine. 2019 Nov 28;37(50):7394-7395. doi: 10.1016/j.vaccine.2017.09.092. Epub 2018 Feb 1.
4
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study.全球、区域和国家 2015 年因呼吸道合胞病毒导致的幼儿急性下呼吸道感染疾病负担估计：系统评价和建模研究。
Lancet. 2017 Sep 2;390(10098):946-958. doi: 10.1016/S0140-6736(17)30938-8. Epub 2017 Jul 7.
5
Passive and active immunization against respiratory syncytial virus for the young and old.针对年轻人和老年人的呼吸道合胞病毒被动免疫和主动免疫。
Expert Rev Vaccines. 2017 Jul;16(7):1-13. doi: 10.1080/14760584.2017.1333425. Epub 2017 Jun 7.
6
Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera.融合前F特异性抗体决定了人血清中呼吸道合胞病毒（RSV）中和活性的大小。
Sci Transl Med. 2015 Oct 14;7(309):309ra162. doi: 10.1126/scitranslmed.aac4241.
7
Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection.评估呼吸道合胞病毒感染婴儿发病机制和疾病严重程度的全血基因表达谱。
PLoS Med. 2013 Nov;10(11):e1001549. doi: 10.1371/journal.pmed.1001549. Epub 2013 Nov 12.
8
Respiratory syncytial virus and recurrent wheeze in healthy preterm infants.呼吸道合胞病毒与健康早产儿反复喘息
N Engl J Med. 2013 May 9;368(19):1791-9. doi: 10.1056/NEJMoa1211917.
9
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.1990年和2010年20个年龄组中235种死因的全球和区域死亡率：全球疾病负担研究2010的系统分析
Lancet. 2012 Dec 15;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0.
10
Respiratory syncytial virus infection in elderly and high-risk adults.老年人及高危成年人的呼吸道合胞病毒感染
N Engl J Med. 2005 Apr 28;352(17):1749-59. doi: 10.1056/NEJMoa043951.
Zotero 插件